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Abstract
Background: Network Tools and Applications in Biology (NETTAB) Workshops are a series of meetings focused on
the most promising and innovative ICT tools and to their usefulness in Bioinformatics. The NETTAB 2011 workshop,
held in Pavia, Italy, in October 2011 was aimed at presenting some of the most relevant methods, tools and
infrastructures that are nowadays available for Clinical Bioinformatics (CBI), the research field that deals with clinical
applications of bioinformatics.
Methods: In this editorial, the viewpoints and opinions of three world CBI leaders, who have been invited to
participate in a panel discussion of the NETTAB workshop on the next challenges and future opportunities of this
field, are reported. These include the development of data warehouses and ICT infrastructures for data sharing, the
definition of standards for sharing phenotypic data and the implementation of novel tools to implement efficient
search computing solutions.
Results: Some of the most important design features of a CBI-ICT infrastructure are presented, including data
warehousing, modularity and flexibility, open-source development, semantic interoperability, integrated search and
retrieval of -omics information.
Conclusions: Clinical Bioinformatics goals are ambitious. Many factors, including the availability of high-throughput
“-omics” technologies and equipment, the widespread availability of clinical data warehouses and the noteworthy
increase in data storage and computational power of the most recent ICT systems, justify research and efforts in
this domain, which promises to be a crucial leveraging factor for biomedical research.
Background
Clinical Bioinformatics (CBI) can be defined as “the clini-
cal application of bioinformatics-associated sciences and
technologies to understand molecular mechanisms and
potential therapies for human diseases” [1]. Being specifi-
cally focused on clinical context, CBI is characterized by
the challenge of integrating molecular and clinical data to
accelerate the translation of knowledge discovery into
effective treatment and personalized medicine. CBI shares
methods and goals with Translational Bioinformatics
(TBI), which has been defined as the “development of sto-
rage, analytic, and interpretative methods to optimize the
transformation of increasingly voluminous biomedical
data - genomic data in particular - into proactive, predic-
tive, preventive, and participatory health management” [2].
CBI and TBI can be thus considered as almost synon-
ymous terms, being both related with the same set of
scientific questions. In this paper we will refer to CBI,
wanting to stress the clinical decision making aspects of
bioinformatics, although we claim that the two terms are
being used in current practice in an interchangeable
manner.
More specifically, CBI is aimed at providing methods
and tools to support two different decision-makers. On
the one hand, it should assist clinicians in dealing with
clinical genomics (biomarker discovery), genomic medi-
cine (identification of genotype/phenotype correlations),
pharmacogenomics and genetic epidemiology at the
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point of care (see [3] for a detailed discussion); on the
other hand, it must support researchers in the proper
reuse of clinical data for research purposes [4]. For this
reason, together with bioinformatics problems, related to
the management, analysis and integration of “-omics”
data, CBI needs to deal with the proper definition of clin-
ical decision-support strategies, an area deeply studied in
the context of medical informatics and artificial intelli-
gence in medicine. CBI is therefore at the confluence of
different disciplines, and may foster the definition of a
comprehensive framework to deal and manage all kinds
of biomedical data, supporting their transformation into
information and knowledge.
Even if the main aim of CBI is very ambitious, there is a
variety of enabling factors that strongly support research
in this direction. First of all, in the last few years new
genome sequencing and other high-throughput experi-
mental techniques have generated vast amounts of mole-
cular data, which, when coupled with clinical data, may
lead to major biomedical discoveries, if properly
exploited by researchers.
Second, new diagnostic and prognostic tests based on
molecular biomarkers are increasingly available to clini-
cians, thus consistently refining the capability of dissect-
ing diseases and, at the same time, enlarging the decision
space on the basis of the improved assessment of risk.
Third, the increasing online availability of the “bib-
liome”, i.e., the biomedical text corpus, made through
published manuscripts, abstracts, textual comments and
reports, as well as direct-to-Web publications, has stimu-
lated the development of new algorithms able to semi-
automatically extract knowledge from these texts so as to
make it available in computable formats. Such algorithms
have been proved to be able to effectively combine the
information reported in the text with that contained in
biological knowledge repositories and are increasingly
used for hypothesis generation, or corroboration of clini-
cal findings. Their use in the clinics poses challenges, but
may be a consistent and important tool to support deci-
sion-making.
Finally, the consistent growth of publicly available data
and knowledge sources and the possibility to easily access
low-cost, high-throughput molecular technologies has
meant that computational technologies and bioinfor-
matics are increasingly central in genomic medicine;
cloud computing technology is being recognised as a key
technology for the future of genomic research to facilitate
large-scale translational research.
Network Tools and Applications in Biology (NETTAB)
Workshops are a series of meetings focused on the most
promising and innovative ICT tools and to their useful-
ness in Bioinformatics [5]. They aim at introducing parti-
cipants to the most promising among evolving network
standards and technologies that are being applied to the
biomedical application domain. Each year, they are
focused on a different technology or domain for which
talks on basic technologies, tools, and platforms of inter-
est, as well as real applications, are presented. The NET-
TAB 2011 workshop, held in Pavia, Italy, in October
2011 was aimed at presenting some of the most relevant
methods, tools and infrastructures that are nowadays
available for CBI.
In this paper, the viewpoints and opinions of three
world CBI leaders, who have been invited to participate
in a panel discussion of the NETTAB workshop on the
next challenges and future opportunities of this field, are
reported.
Looking at CBI from the technological side, these
experts have identified three areas that need advancement
and further research. These include the development of
data warehouses and ICT infrastructures for data sharing,
the definition of standards for sharing phenotypic data
and the implementation of novel tools to implement effi-
cient search computing solutions. In the following of the
editorial we report such opinions and discuss their rele-
vance to the field.
ICT infrastructures for supporting clinical bioinformatics:
important design features of the i2b2 system
i2b2 (Informatics for Integrating Biology and the Bed-
side) is an NIH-funded National Center for Biomedical
Computing based at Partners HealthCare System that is
an integrated framework for using clinical data for
research [4].
The back end of i2b2 has a modular software design,
called the ‘Hive,’ that manages everything having to do
with how data is stored and accessed. The front end of
i2b2 is the i2b2 Web client, a user interface that allows
researchers to query and analyze the underlying data. The
software is open source and can be extended by users
once the core cells of the Hive are included and correctly
configured.
To date, i2b2 has been deployed at over 70 sites
around the world, where it is being used for cohort
identification, hypothesis generation and retrospective
data analysis. At many of these sites, additional func-
tionality is being developed to suit the needs of the
researchers.
Several aspects of i2b2 contribute to its rapid adoption
by the clinical research community. The first is that it is
open source and therefore not only is it free to try, but
there is a built-in set of collaborators - other users - with
whom to engage both to get help with any questions and
to foster innovation. The open source, self-service nature
of i2b2 allows investigators to try out ideas stepwise at
their own pace and at no financial cost. The online docu-
mentation and community wiki are kept up-to-date and
greatly assist in user support. Secondly, both the fact that
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it is open source and the modularity of the design enforce
backward compatibility with existing research, so that it
is added to the i2b2 platform and does not become
obsolete.
But perhaps the key to the utility of i2b2 is the simpli-
city of its database design. A research data warehouse
typically includes data from disparate sources, such as
electronic health records, administrative systems, genetic
and research data, and lab results, to name a few. The
structure of the i2b2 database allows this data to be
aggregated and optimized for rapid cross-patient search-
ing in a way that is transparent to the user. The specific
design and flexibility of the data model supports new
research data being added to the database as it is
amassed, while allowing users to construct complex
queries against the multiple source systems.
i2b2 data is stored in a star schema, first described by
Kimball [6]. A very large central fact table (observation_-
fact) is surrounded by and connected to the smaller
dimension tables, i.e., the patient, observer, visit, concept
and modifier dimensions (Figure 1). A fact is defined as
an observation on a patient, made at a specific time, by a
specific observer, during a specific event. Dimension
tables hold descriptive information and attributes about
the facts.
The star schema is optimized for analytic querying and
reporting. Its design tends to mirror the way users think
about and use data, which is important since users must
understand what data is available in order to formulate
queries. The straightforward connections between the
fact and dimension tables mean that navigation through
the database via joins and drilling into or rolling up
dimensional data is simple and quick. The design allows
the fact table to grow to billions of rows while maintain-
ing performance. Another advantage of the fact table
design is that it is well suited to handle “sparse” data;
data that has many possible attributes (such as all possi-
ble medical concepts), but with only a few that are
applicable. In this model, only positive facts are recorded,
thus resulting in more efficient storage.
Perhaps the most powerful aspect of the i2b2 database
design is the design of the metadata. In i2b2, metadata is
the vocabulary, all the medical terms that describe the
facts in the database. Metadata is what allows users to
interact with the database. A typical clinical data ware-
house may have 100,000 to 500,000 concepts, including
Figure 1 The i2b2 star schema.
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ICD-9 [7], SNOMED-CT [8], CPT [9], HCPCS [10],
NDC [11] and LOINC [12] codes, as well as a host of
local codes from in-house systems. Without an intuitive
and easy-to-use structure, users would be stymied in
understanding and using the codes. In i2b2, a hierarchical
folder system is used to group the concepts. General
terms are located in higher level folders, with more speci-
fic but related terms in folders and leaves underneath.
The way the metadata looks in the i2b2 Web client
directly reflects its structure in the table (Figure 2). A
user can drill up and down in the folders in the user
interface to clearly see the hierarchy and find terms of
interest.
Maintaining and updating the metadata is a signifi-
cant, but workable challenge. New medical codes are
constantly being created, and old codes are discarded or
changed. The structure of the metadata must be able to
seamlessly absorb new codes while remaining backward
compatible with old coding schemes. The hierarchical
classification scheme of i2b2 makes it easy to map new
codes to existing folders and to create new folders as
needed. Entire new coding systems can be added just by
creating a new folder. Discarded codes can remain in
the hierarchy next to newer ones and used to reference
older data, or hidden to discourage their usage in new
queries.
One goal of i2b2 is to help integrate data from the
many different sources that exist in modern day health-
care institutions in order to present a comprehensive
view of patient care for research. The simple and intui-
tive design of the i2b2 database enables users to con-
struct complex queries over these disparate data sources.
Using the new generation of Healthcare and Life Sciences
standards for Personalized Medicine
The success of Personalized Medicine (PM) at the point
of care is dependent on the effective use of PM knowl-
edge (e.g., pharmacogenomic interpretation of somatic
Figure 2 The i2b2 Web Client is shown. The characteristic terms (and their respective modifiers) that describe the patients in the Clinical
Research Chart are shown in the tree structure on the left. The query is composed in the upper right with the logic of a “Venn-Diagram”. Terms
in two different Groups will be logically ANDED together, and number of patients will be shown after computation, in this case the number of
patients who are both male and have had appendicitis.
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mutations in tumor tissues) while considering the com-
plete patient’s medical history (e.g., other diseases, medi-
cations, allergies, and genetic mutations).
In order for PM knowledge to be effectively applied to
the patient medical records, representations of data and
knowledge need to be standardized due to the heteroge-
neity of their original formats. Both data and knowledge
are generated nowadays by a variety of sources, each of
them using proprietary formats and idiosyncratic seman-
tics, often not represented explicitly (for example, when
contextual data is unstructured and thus cannot be
parsed by decision support applications).
Interpretation of clinical data typically starts at parsing
the metadata, e.g., the predefined schemas of clinical
information systems. However, these schemas (most
often relational) cannot accommodate the complexity of
contextual data representation. Thus, it is important to
have a richer language allowing the explicit representa-
tion of patient-specific context of each discrete data item
and of how it relates to other data items, as well as how
it fits within the entire health history of an individual.
Dispersed and disparate medical records of a patient
are often inconsistent and incoherent. A patient-centric,
longitudinal electronic health record (EHR) based on
international standards (e.g., CEN EHR 13606 [13]) could
provide a coherent and explicit representation of the
data’s semantics. New PM evidences, generated by clini-
cal research and validated in clinical trials and by data
mining, should be represented in alignment with clinical
data representations in a way that lends itself to PM reali-
zation. A constantly growing stream of raw data is avail-
able today in both research and clinical environments,
e.g., DNA sequences and expression data along with rare
variants and their presumed affected function, as well as
sensor data along with deduced personal alerts.
The representation of such raw data should adhere, as
much as possible, to common and agreed-upon reference
models (e.g., HL7/ISO RIM - Reference Information
Model [14] or the openEHR RM - Reference Model [13])
that provide unified representations of the common con-
structs needed for health information representation. For
example, any observation could be represented in the
same way in terms of its attributes, such as id, timing,
code, value, method and status, but more importantly,
using the same reference models could lead to the stan-
dard representation of clinical statements (e.g., “observa-
tion of gall bladder acute inflammation indicated having
a procedure of cholecystectomy”, or “EGFR variations
cause resistance to Gefitinib”), where implicit semantics
can become explicit and thus processable by decision
support applications.
The abovementioned reference models can underlie
the logical models of health data warehousing. Such
warehousing could maintain the richest semantic
representation of data and knowledge in a way that is
also interoperable with other information systems. Per-
forming specific tasks, such as summarizing patient data
or analyzing cohort data in research studies, needs more
optimized representations of the data and knowledge
persisted in warehouses. Data marts are such optimized
representations, and multiple data marts could be
derived from a single warehouse. For example, the star
schema underlying the i2b2 framework (see Figure 1)
could be seen as a generic data mart for translational
research that could be based on data exported from a
standardized data warehouse maintained by a single
health organization or across organizations, such as in
the case of clinical affinity domains or integrated deliv-
ery networks.
In many cross-enterprise warehousing efforts, the
main format used to convey patient data is the Clinical
Document Architecture (CDA) standard [15]. CDA
documents strike a balance between physicians’ narra-
tives and structured data in order to facilitate the gra-
dual transition from unstructured clinical notes to
standardized and structured data. The same transforma-
tion should also take place in knowledge representa-
tions, from scientific papers in natural language to
structured knowledge, for example.
The efforts to apply Natural Language Processing
(NLP) to health information could be connected to
healthcare information technologies through standards
like CDA that uses the clinical statement concept. The
NLP fundamentals can be reduced to the clinical state-
ment constituents and the CDA can thus be a good
“catcher” of the results of NLP running over unstruc-
tured health information.
Search and extraction of relevant information from big
data amounts
The continuously increasing amount of available data
poses significant technological and computational chal-
lenges, both to their management (collection, storage, inte-
gration, preservation) and effective use (access, sharing,
search, extraction, analysis). This issue is becoming predo-
minant in several fields and it is being addressed in differ-
ent ways, according to each specific field peculiarities.
The Web is a paradigmatic field for this aspect. A
rapidly growing mass of data is flooding the Web. Yet,
leveraging on the typical linked nature of Web data, tech-
nological and computational advancements are prevent-
ing (at least for now) drowning by Web data. Automatic
robots have been implemented to crawl the Web
resources, collect their huge key data and store them in
powerful database management systems. Effective index-
ing and ranking techniques, such as the Google PageRank
[16], have been implemented to efficiently catalogue and
sort Web resources according to their key data and likely
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relevance. This enables Web search engines to provide
lists of items which often include among their top 10 or
20 items the one(s) that can reasonably answer numer-
ous, yet simple, user search questions.
Such ability, which is tremendously boosting the Web
as an extraordinary easy-to-use source of information, is
based on the assumption that user searches are mainly
aimed at finding “at least one“ or “the most evident“ item
that can answer his/her question. Current Web search
technologies are not enough when search questions
either become more complex, simultaneously involve dif-
ferent topics, or require the retrieval of most of (if not
all) available items regarding the question, possibly
ordered according to different user-defined features.
Furthermore, only an estimated limited part of all data
accessible through the Web can actually be found by cur-
rent search engines: the vast “deep Web“, including
dynamic pages returned in response to a query or
accessed through a form, resources protected by pass-
word, sites limiting access by using various security tech-
nologies (e.g., CAPTCHAs), and pages that are accessible
through link-produced scripts, remains unrevealed.
Especially in the CBI field, the amount of collected data
is continuously and rapidly increasing, in particular with
the recent collection of -omics data. Also, compared to
the Web, the current ability of extracting relevant biome-
dical information and of answering even common CBI
questions is far less, due to many reasons.
First, the biomedical-molecular data - which are of var-
ious types - are stored in several different formats within
systems that are distributed, heterogeneous, and often
not interoperable. Furthermore, a lot of important infor-
mation is subjectively described in free texts, within chief
complaints, discharge letters, clinical reports or referrals,
which are intrinsically unstructured. The adoption of
electronic medical or health records can significantly
enhance the availability and sharing of clinical data and
information, which are still only on paper in very many
healthcare sites. Yet, the digitalization of health data
alone is far from sufficient; having clinical reports and
referrals in PDF format is evidently not enough to solve
the information extraction and question answering
issues. A standard data and information representation
according to a shared reference model has to be adopted,
together with controlled terminologies and ontologies to
objectively describe medical and biomolecular findings.
Moreover, the use of advanced Natural Language Proces-
sing techniques suited for the clinical domain to extract
and structure information from previous medical textual
descriptions can also greatly help.
Second, usual biomedical-molecular questions are gen-
erally more complex than Web search questions. They
often involve more types of data, as well as topics with
usually several attributes. In many cases, retrieving only a
few of the items related to a biomedical-molecular search
question, or even the K top items according to some
user-defined ranking, may not be enough for a proper
answer, which can instead require the exploration of all
available items and their attributes.
Advanced search computing techniques are being
developed to answer complex, multi-topic Web search
questions involving the integration of possibly ranked
partial search results [17]. These techniques can also be
applied in the CBI domain to tackle such issues, at least
partially. Yet, the complex and heterogeneous nature of
the biomedical data, as well as the multifaceted struc-
ture of the clinical settings, pose formidable technologi-
cal and organizational challenges for the effective
management and use of biomedical-molecular data. In
particular, integrated search and retrieval of bio-data,
and their comprehensive analysis towards extraction of
relevant information [18] and inference of biomedical
knowledge, constitute some of the major challenges for
the present and future of CBI, with a potential remark-
able impact on the advancement of clinical research and
patient treatment.
Conclusions
CBI goals are ambitious, but many factors, from the
availability of high-throughput “-omics” technologies
and equipment, allowing identifying “individual” gen-
omes and proteomes, to the incredible increase in data
storage and computational power that is allowed by
most recent ICT systems, justify research and efforts in
this domain.
In this paper, we have reported some points of view
on the current and future challenges in this domain that
were discussed in a panel session at the NETTAB 2012
workshop on Clinical Bioinformatics.
First, we presented what we believe are the most
important design features of a CBI-ICT infrastructure,
by taking into account some achievements of the i2b2
system. Data warehousing is essential in CBI because of
the great amount of clinical and biomedical information
that needs to be generated and managed within health
organizations. Indeed, CBI depends on information that
is gathered from single individuals, usually patients, and
thus it cannot exclusively depend on general population
or species oriented databases that are available on-line
from main data providers. On the contrary, these gen-
eral resources may only be used as a general reference,
while the most important data is provided by indivi-
dual’s clinical and molecular information.
Some of the most relevant features of a data ware-
house for CBI have been identified by examining the
i2b2 experience. Simplicity of the database schema is a
key factor, facilitating the modularity and flexibility of
the system, that support its continuous development
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and improvement, and making optimization of queries
and searches possible. Modularity is indeed essential
also because of the various and heterogeneous data and
sources that may be usefully included in the data ware-
house, thus leading to a multiplicity of goals and appli-
cation domains for the system.
The open source approach is also extremely impor-
tant, since it is able to fully exploit collaboration among
users both for software development and for new fea-
tures design. Collaborative development is especially
important for the maintenance and update of shared
metadata that, being used by the users as the main
means to interact with the database, determine in fact
its real usefulness and success.
Of course, individuals are moving, and information is
being accumulated in many health organizations and
information systems, that need to interoperate so that all
possible information on each patient is made swiftly avail-
able when it is needed. This is a precondition for the clini-
cians in order to be able to deal at the point of care with
all needed information for a proper, molecular-enabled,
diagnosis, prognosis and optimized treatment selection.
Moreover, CBI data analysis may be greatly facilitated
and improved when the population under analysis is the
greatest possible. Such clinical-related processes as bio-
marker discovery and identification of genotype/pheno-
type correlations may only be carried out when a
sufficient amount of data is available. So, interoperation
of information systems should support both integration
of data on single individuals and coming from many
patients. Hence, it is of extreme relevance.
In this paper, we have therefore also faced the intero-
perability issue, and we have discussed about some of
the most recent standards for data modelling and data
interchange and their possible use in CBI to overcome
heterogeneity of original data and knowledge formats, as
well as modelling of arising information. In this case,
international standards exist and should be adopted,
with the provision that new evidence arising as a result
of genomic medicine efforts be also properly included.
We also highlighted that the application of a shared
reference model could lead to a standard, semantics
rich, processable representation of clinical statements.
CBI is not limited, however, to the analysis of the infor-
mation on a given individual by the health care personnel
that provide him/her assistance. As previously said, it
must also support researchers in the reuse of clinical data
for research purposes. Many new applications are being
developed by researchers in the field, who can largely
benefit from making access and searching information
resources through Web services. It is often from such
free access to data that new associations may be identi-
fied, possibly leading to hypothesis for new biomarkers
validation and assessment.
In this paper, we have therefore also tried to point out
which currently are the main difficulties in making
access and searching CBI related information sources.
First, we addressed the idea that the adoption of com-
mon data models could be the best starting point for
the implementation of a set of data marts, optimized
representations of data included in warehouses for per-
forming specific research tasks. New data marts, each
devoted to a different task, could easily be created and
made available.
Current techniques and technologies aimed at search-
ing data on the Web, even the most advanced, do not
seem completely adequate for CBI needs, where queries
are complex, involving many data sources simulta-
neously and, often, requesting from each resource more
results than the first that are usually returned. One of
the most demanding issues remains access to a lot of
information that is included, and subjectively described,
in free texts, which are intrinsically unstructured. The
use of controlled terminologies and of ontologies, when-
ever possible, together with the adoption of NLP tools
suited for the clinical and biological domains can indeed
support extraction of information from medical textual
descriptions.
We finally moved to the issue of searching and
extracting information from big data amounts. Queries
which are relevant in CBI often require retrieving result
sets bigger than usual and the exploration of all avail-
able items and their attributes because of possible corre-
lations among data in the results that could change,
even sensibly, their relevance to the overall query. Of
particular interest are those advanced search computing
techniques, which are aimed at integrating ranked
search results from multiple sources.
The integrated search and retrieval of CBI data from
multiple sources and its comprehensive analysis consti-
tute in our opinion one of the biggest challenges for the
future. The NETTAB 2013 workshop will be devoted to
this theme.
List of abbreviations used
CBI: Clinical Bioinformatics; CDA: Clinical Document Architecture; CEN:
Comité Européen de Normalisation (European Committee for
Standardization); CPT: Current Procedural Terminology; EHR: Electronic Health
Record; HCPCS: Healthcare Common Procedure Coding System; HL7: Health
Level 7; i2b2: Informatics for Integrating Biology and the Bedside; ICD-9:
International Classification of Diseases rel. 9; ISO: International Standard
Organization; LOINC: Logical Observation Identifiers Names and Codes; NDC:
National Drug Code; NETTAB: Network Tools and Applications in Biology;
NIH: National Institute of Health; NLP: Natural Language Processing; RIM:
Reference Information Model; RM: Reference Model; SNOMED: Systematized
Nomenclature of Medicine; TBI: Translational Bioinformatics.
Acknowledgements
This work was supported in part by the project Onco-i2b2, funded by
“Regione Lombardia”, and by the FIRB project ITALBIONET, funded by the
Italian Ministry of Research.
Bellazzi et al. BMC Bioinformatics 2012, 13(Suppl 14):S1
http://www.biomedcentral.com/1471-2105/13/S14/S1
Page 7 of 8
This article has been published as part of BMC Bioinformatics Volume 13
Supplement 14, 2012: Selected articles from Research from the Eleventh
International Workshop on Network Tools and Applications in Biology
(NETTAB 2011). The full contents of the supplement are available online at
http://www.biomedcentral.com/bmcbioinformatics/supplements/13/S14
Author details
1Dipartimento di Ingegneria Industriale e dell’Informazione, Università di
Pavia, Via Ferrata 1, 27100, Pavia, Italy. 2Dipartimento di Elettronica e
Informazione - Politecnico di Milano, Milano, Italy. 3Harvard Medical School,
Boston, MA, USA. 4IBM Research Lab in Haifa, Israel. 5IRCCS AOU San Martino
- IST Istituto Nazionale per la Ricerca sul Cancro, 16132, Genova, Italy.
Authors’ contributions
RB and PR conceived the work, wrote the background and introduction and
drafted the conclusions. MM, SM, and AS contributed by identifying and
specifying issues in one of the three main chapters, respectively on data
search and extraction, data warehouse platform, and standardization and
interoperability. All authors revised, discussed, and amended the manuscript
and approved its final version.
Competing interests
The authors declare that they have no competing interests.
Published: 7 September 2012
References
1. Wang X, Liotta L: Clinical bioinformatics: a new emerging science. Journal
of Clinical Bioinformatics 2011, 1(1):1.
2. Butte AJ: Translational bioinformatics: coming of age. Journal of the
American Medical Informatics Association 2008, 15(6):709-714.
3. Sarkar IN, Butte AJ, Lussier YA, Tarczy-Hornoch P, Ohno-Machado L:
Translational bioinformatics: linking knowledge across biological and
clinical realms. Journal of the American Medical Informatics Association 2011,
18(4):354-357.
4. Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I:
Serving the enterprise and beyond with informatics for integrating
biology and the bedside (i2b2). Journal of the American Medical
Informatics Association 2010, 17(2):124-130.
5. NETTAB Workshops. [http://www.nettab.org/].
6. Kimball R: The Data Warehouse Toolkit: practical techniques for building
dimensional data warehouses. New York, NY: John Wiley & Sons, Inc;,
Second 2002.
7. ICD-9. [http://www.cdc.gov/nchs/icd/icd9.htm].
8. SNOMED-CT. [http://www.ihtsdo.org/snomed-ct/].
9. CPT - Current procedural terminology. [http://en.wikipedia.org/wiki/
Current_Procedural_Terminology].
10. HCPCS - Healthcare common procedure coding system. [http://www.cms.
gov/Medicare/Coding/MedHCPCSGenInfo/index.html].
11. NDC - National Drug Code. [http://en.wikipedia.org/wiki/
National_Drug_Code].
12. LOINC - Logical Observation Identifiers Names and Codes. [http://loinc.
org/].
13. European Committee for Standardization (CEN) - Semantic
interoperability in the electronic health record communication. [http://
www.en13606.org/].
14. HL7 (Health Level Seven) Version 3 Standard: Foundation (Reference
Information Model, Data Types and Vocabulary). [http://www.hl7.org/
v3ballot/html/welcome/environment/index.html].
15. Dolin RH, Alschuler L, Boyer S, Beebe C, Behlen FM, Biron PV, Shabo Shvo A:
HL7 Clinical Document Architecture, Release 2. J Am Med Inform Assoc
2006, 13(1):30-39.
16. Langville AN, Meyer CD: Google’s PageRank and beyond: the science of
search engine rankings. Princeton, NJ, Princeton University Press; 2006.
17. In New Trends in Search Computing. Volume 6585. Heidelberg, D, Springer,
LNCS;Ceri S, Brambilla M 2011.
18. Masseroli M, Ghisalberti G, Ceri S: Bio-Search Computing: integration and
global ranking of bioinformatics search results. Journal of Integrative
Bioinformatics 2011, 8(2):166, p. 1-9.
doi:10.1186/1471-2105-13-S14-S1
Cite this article as: Bellazzi et al.: Clinical Bioinformatics: challenges and
opportunities. BMC Bioinformatics 2012 13(Suppl 14):S1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bellazzi et al. BMC Bioinformatics 2012, 13(Suppl 14):S1
http://www.biomedcentral.com/1471-2105/13/S14/S1
Page 8 of 8
